{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:24:03Z","timestamp":1789788243652,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.critrevonc.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T14:41:42Z","timestamp":1457188902000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers"],"prefix":"10.1016","volume":"101","author":[{"given":"Jean-Baptiste","family":"Delhorme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley S.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Severac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelle C.","family":"Freel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Rohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Brigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2016.03.001_bib0005","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0010","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/cncr.29092","article-title":"Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors","volume":"121","author":"Anderson","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","author":"Anonymous","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0020","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0025","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/cncr.25901","article-title":"Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal","volume":"117","author":"Bazan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0030","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","article-title":"Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11","volume":"28","author":"Ben-Josef","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ygyno.2014.03.561","article-title":"Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status","volume":"134","author":"Bristow","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.6004\/jnccn.2014.0068","article-title":"International adaptations of NCCN clinical practice guidelines in oncology","volume":"12","author":"Carlson","year":"2014","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0045","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.amjsurg.2014.03.010","article-title":"Association between surgeon characteristics and their preferences for guideline-concordant staging and treatment for rectal cancer","volume":"208","author":"Charlton","year":"2014","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0050","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/0360-3016(91)90265-6","article-title":"Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C","volume":"21","author":"Cummings","year":"1991","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0060","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13014-014-0240-4","article-title":"Interstitial high-dose rate brachytherapy as boost for anal canal cancer","volume":"9","author":"Falk","year":"2014","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.03.00060803","article-title":"Lung cancer: the importance of seeing a respiratory physician","volume":"21","author":"Fergusson","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0070","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/annonc\/mdu188","article-title":"Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.radonc.2014.04.013","article-title":"Anal cancer: eSMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"111","author":"Glynne-Jones","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0080","first-page":"251","article-title":"Epid\u00e9miologie du cancer de lanus","volume":"3","author":"Grabar","year":"2011","journal-title":"Canc\u00e9ro Dig."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00384-013-1778-6","article-title":"Age impacts the pattern of care for elderly patients with rectal cancer","volume":"29","author":"Guillerme","year":"2014","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0090","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0095","article-title":"Variations in guideline-concordant breast cancer adjuvant therapy in rural Georgia","author":"Guy","year":"2014","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ijrobp.2010.02.055","article-title":"High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study)","volume":"80","author":"Hannoun-Levi","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ijrobp.2015.03.011","article-title":"Does cancer literature reflect multidisciplinary practice? A systematic review of oncology studies in the medical literature over a 20-Year period","volume":"92","author":"Holliday","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0110","first-page":"137304","article-title":"Guideline concordant therapy prolongs survival in HER2-positive breast cancer patients: results from a large population-based cohort of a cancer registry","author":"Inwald","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0115","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0120","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/cncr.28683","article-title":"Guideline-concordant cancer care and survival among American Indian\/Alaskan Native patients","volume":"120","author":"Javid","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973\u20132000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of Dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0135","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00066-014-0628-y","article-title":"Role of brachytherapy in the treatment of cancers of the anal canal long-term follow-up and multivariate analysis of a large monocentric retrospective series","volume":"190","author":"Lestrade","year":"2014","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2015.02.008","article-title":"Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial","author":"Levy","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0145","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.14694\/EdBook_AM.2015.35.e583","article-title":"Assuring quality cancer survivorship care: we\u2019ve only just begun","volume":"35","author":"Mayer","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0150","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.ijrobp.2012.09.034","article-title":"Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study)","volume":"85","author":"Moureau-Zabotto","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jgo.2015.01.001","article-title":"Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States","volume":"6","author":"Nadpara","year":"2015","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/v10019-012-0022-2","article-title":"Long term outcome after combined modality treatment for anal cancer","volume":"46","author":"Oblak","year":"2012","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1200\/JCO.2014.58.7543","article-title":"Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base","volume":"33","author":"Olszewski","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0170","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0175","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2007.12.0170","article-title":"Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience","volume":"25","author":"Salama","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.03.001_bib0180","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0360-3016(89)90519-1","article-title":"Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases","volume":"17","author":"Schlienger","year":"1989","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816300427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816300427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T15:50:48Z","timestamp":1536940248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842816300427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":36,"alternative-id":["S1040842816300427"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.03.001","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}